Edwards Lifesciences Corp EW

Morningstar Rating

Edwards Gains Strength in Transcatheter Mitral and Tricuspid Valves as TAVR Matures

Business Strategy and Outlook

Over the last two decades, Edwards Lifesciences has demonstrated that it knows how to maintain leadership through innovation of tissue heart valves. Edwards remains the dominant force in surgical heart valves and minimally invasive valve therapy—one of the hottest areas in cardiac devices.

Sponsor Center